CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,144,286
- in 6 filings, $22.1M under 10b5-1 plans
Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-10 | LaBarre Michael J. SVP, Chief Technical Officer | Grant or award · Option to Purchase Common Stock | +69,174 | 69,174 | ||
| 2020-02-10 | LaBarre Michael J. SVP, Chief Technical Officer | Grant or award · Restricted Stock Units | +32,533 | 32,533 | ||
| 2020-02-10 | Stelzer Laurie SVP, Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +69,174 | 69,174 | ||
| 2020-02-10 | Stelzer Laurie SVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +32,533 | 32,533 | ||
| 2020-02-10 | Torley Helen President and CEO | Grant or award · Option to Purchase Common Stock | +266,051 | 266,051 | ||
| 2020-02-10 | Torley Helen President and CEO | Grant or award · Restricted Stock Units | +125,126 | 125,126 | ||
| 2020-02-03 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +11,559 | 165,782 | ||
| 2020-02-03 | LaBarre Michael J. SVP, Chief Technical Officer | Shares withheld for taxes | −4,289 | $19.21 | $82K | 161,493 |
| 2020-02-03 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Common Stock | +11,559 | 0 | ||
| 2020-02-03 | Stelzer Laurie SVP, Chief Financial Officer | Exercise or conversion | +23,119 | 105,081 | ||
| 2020-02-03 | Stelzer Laurie SVP, Chief Financial Officer | Shares withheld for taxes | −8,275 | $19.21 | $159K | 96,806 |
| 2020-02-03 | Stelzer Laurie SVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −23,119 | 0 | ||
| 2020-02-03 | Torley Helen President and CEO | Exercise or conversion | +55,487 | 459,567 | ||
| 2020-02-03 | Torley Helen President and CEO | Shares withheld for taxes | −19,910 | $19.21 | $382K | 439,657 |
| 2020-02-03 | Torley Helen President and CEO | Exercise or conversion · Restricted Stock Units | −55,487 | 0 | ||
| 2019-10-01 | Hickey Benjamin SVP, Chief Commerical Officer | Exercise or conversion | +20,216 | 20,216 | ||
| 2019-10-01 | Hickey Benjamin SVP, Chief Commerical Officer | Shares withheld for taxes | −6,990 | $15.46 | $108K | 13,226 |
| 2019-10-01 | Hickey Benjamin SVP, Chief Commerical Officer | Exercise or conversion · Restricted Stock Units | −20,216 | 60,647 | ||
| 2019-08-03 | Chondros Dimitrios SVP, Chief Medical Officer | Sale | −1,328 | $16.70 | $22K | 38,584 |
| 2019-06-15 | Stelzer Laurie SVP, Chief Financial Officer | Exercise or conversion | +6,875 | 85,370 |
Page 58 of 59 · 1,177 trades